LIVE 2021 [THE DEFINITIVE GUIDE TO RBQM FOR EXPERTS AND BEGINNERS] Join Ken Getz, Professor of Tufts CSDD and other experts at RBQM Live on May 20-21, to discuss how we, as an Industry, can continue to leverage RBQM to build safer, more efficient trials of the future. GET YOUR Free E-PASS
About
[#RBQMLIVE]
The Virtual Event of '21

The adoption of Risk-Based Quality Management, the process of identifying, monitoring, and mitigating the risks that could impact the quality or safety of a clinical trial, is accelerating. Organizations are benefitting from reduced study timelines, increased efficiency, and enhanced patient safety. Join us on May 20-21, 2021 to discuss how we can continue to leverage RBQM to build safer, more efficient clinical trials of the future.

Until the day of

the event…

#RBQMLive
[FEATURED SPEAKERS]
Meet the Speakers

Ken Getz

[Professor, Tufts Center for the Study of Drug Development]

Lynne Cesario

[Global Risk-Based Monitoring Program Lead, Pfizer]

Sy Pretorius

[President, Clinical Development and Chief Medical Officer, Parexel]

Jacqueline Gough

[Jacqueline Gough, Director, Central Monitoring, Alexion Pharmaceuticals]

Esther Huffman O’Keefe

[Associate Director - Monitoring, Regeneron Pharmaceuticals]

Mary Arnould

[Director, Astellas Pharma]
#RBQMLive
[EVENT PARTNERS]